Page last updated: 2024-08-24

gallocatechol and Idiopathic Parkinson Disease

gallocatechol has been researched along with Idiopathic Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cima-Omori, MS; Dominguez-Meijide, A; Griesinger, C; Ibáñez de Opakua, A; König, A; Leonov, A; Outeiro, TF; Ryazanov, S; Vasili, E; Zweckstetter, M	1

Other Studies

1 other study(ies) available for gallocatechol and Idiopathic Parkinson Disease

Article	Year
Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization. Scientific reports, 2020, 07-30, Volume: 10, Issue:1 Topics: alpha-Synuclein; Alzheimer Disease; Benzodioxoles; Benzopyrans; Brain; Catechin; Cells, Cultured; Humans; Hydrazones; Lewy Bodies; Molecular Targeted Therapy; Neurofibrillary Tangles; Parkinson Disease; Protein Aggregates; Protein Aggregation, Pathological; Pyrazoles; tau Proteins	2020

Article

Year

Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization.

Scientific reports, 2020, 07-30, Volume: 10, Issue:1

Topics: alpha-Synuclein; Alzheimer Disease; Benzodioxoles; Benzopyrans; Brain; Catechin; Cells, Cultured; Humans; Hydrazones; Lewy Bodies; Molecular Targeted Therapy; Neurofibrillary Tangles; Parkinson Disease; Protein Aggregates; Protein Aggregation, Pathological; Pyrazoles; tau Proteins

2020